Temperature mapping is one of those topics that makes a lot of pharmaceutical companies uncomfortable. They know they need to do it, but many aren't entirely sure why, or what a rigorous mapping study involves. According to Marisa Meinero, GxP expert at ELPRO, that discomfort is more common than the industry lets on. And this may point to a misunderstanding of what temperature mapping is really for.
More Than a Regulatory Requirement
In GxP temperature mapping compliance, the regulatory obligation is real. Guidelines from the WHO, GDP and other authorities make that clear. But if compliance is the only reason a company pursues a mapping study, they're missing most of the value.
“Most companies come to us because they had an audit. They don't come to us because they want to do a mapping.”
Marisa Meinero , Qualification Engineer, ELPRO
That reactive posture is understandable, but it leaves companies without the foundational knowledge their storage operations depend on.
A well-executed pharmaceutical storage mapping study does something no risk assessment spreadsheet or HVAC (Heating, Ventilation and Air Conditioning) specification can do: it tells you how your specific storage system behaves under real conditions. Are there hot and cold spots that aren't obvious? How does the system respond when a door is left open for several minutes? What happens to a walk-in unit during a power failure? These aren't hypotheticals — they're scenarios that mapping studies are designed to test.
The answers inform everything from Standard Operating Procedure (SOP) development to alarm configuration to staff training. Without them, decisions are based on assumptions. With them, they're based on evidence.
Mapping and Monitoring: Understanding the Difference
One of the most common points of confusion in pharmaceutical temperature management is the relationship between mapping and monitoring. For companies newer to GxP requirements, the two are often conflated, and that confusion can lead to gaps in both compliance and product protection.
Temperature mapping is a time-limited distribution study performed on a storage unit. It characterizes the thermal behavior of that space under defined conditions and identifies the locations most at risk for temperature excursions. Monitoring, by contrast, is the ongoing, continuous surveillance of those conditions in daily operation.
Critically, mapping comes first. The placement of your permanent monitoring sensors should be informed by the mapping study, specifically by where the mapping identified the most critical locations. Without completing a mapping study first, monitoring sensor placement is essentially a guess.
What Temperature Mapping Risk Management Actually Looks Like
Risk-based thinking is central to GxP, but it can become a vague justification for skipping steps. Temperature mapping risk management that pharma professionals take seriously means using real data, not assumptions, to define the boundaries of safe storage.
Consider a refrigeration unit. Common sense might suggest it's probably fine. But a mapping study may reveal that one corner consistently runs warmer than the rest of the unit, or that door openings during busy periods cause temperature spikes that persist longer than expected. That data is what allows a quality team to set a meaningful SOP: not “keep the door closed when possible,” but “door openings must not exceed three minutes, as mapping data shows excursions beyond this duration.”
This is the difference between an SOP rooted in real knowledge and one rooted in general practice. The former holds up under scrutiny. The latter doesn't: not under audit, and not when a temperature excursion puts a product batch at risk.
Documentation: Where Mapping Studies Succeed or Fail
In Marisa's experience, temperature mapping documentation audit failures are rarely about the mapping itself. They're about how the study was planned, executed and recorded.
The mapping layout is the foundation. Before a single sensor is placed, the storage unit must be thoroughly analyzed: its dimensions, air circulation patterns, proximity to windows or external walls, HVAC configuration, and any other internal or external influences. A mapping layout that doesn't account for these factors will produce data that's incomplete at best and misleading at worst.
Duration is another common failure point. International guidelines specify minimum mapping durations, typically starting at 24 hours for small freezers and refrigerators and scaling upward based on unit size, complexity and outside temperature influence. Some studies require seven days or more. In certain cases, particularly for storage units with significant seasonal exposure, ELPRO recommends extending studies to three or four weeks to capture meaningful temperature variation. Cutting a mapping short without documented justification is one of the issues auditors look for consistently.
Then there's the documentation discipline itself. Deviations from the original protocol need to be explained and justified in the record: a shorter duration, a change in sensor placement, an environmental anomaly during the study. Customers who manage their own mapping documentation frequently run into problems here. The discipline required for good documentation practices isn't intuitive; it needs to be trained and reinforced.
“When customers perform the mapping themselves, mistakes occur more often when uncertainties are not clarified with us. You may start with a mapping duration of 72 hours but then only do 24 hours without an explanation for it.”
Marisa Meinero, Qualification Engineer, ELPRO
The Business Case: What's at Stake
The consequences of inadequate or missing temperature mapping extend well beyond audit findings. They reach the patients at the end of the supply chain.
“In the end, it could cost more — money, lives, reputation. The main argument for getting it right, for ELPRO and all these pharma companies, is that they are aiming for one goal: to provide safe medicine for patients who need it.”
Marisa Meinero , Qualification Engineer, ELPRO
An audit failure is serious. A product recall is more serious. But the scenario that no pharmaceutical company wants to contemplate is a patient harmed by a drug whose integrity was compromised somewhere in storage, in a facility whose conditions were never properly characterized or verified.
Bringing in a qualified external partner for a mapping study is not just about passing the next inspection. It's about having the confidence that when something disrupts your storage environment, whether a heat wave, a power outage, or an HVAC failure, your protocols were written with real data behind them.